Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Montoro, J; Eikema, DJ; Piepenbroek, B; Tuffnell, J; Halahleh, K; Kulagin, A; Alahmari, A; Aksoy, BA; Remenyi, P; Itaela-Remes, M; Gulbas, Z; Mcdonald, A; Apte, S; Kwon, M; Rovira, M; Kharya, G; Potter, V; Gambella, M; Schroeder, T; Giammarco, S; Bazarbachi, A; Aljurf, M; Ho, ALY; Dalle, JH; Vydra, J; Sanz, J; Perez-Simon, JA; Colita, A; Collin, M; Tanase, A; Halkes, C; Kulasekararaj, A; Risitano, A; de Latour, RP.

Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT

BONE MARROW TRANSPLANTATION. 2025; 60(8): 1152-1159 [doi:10.1038/s41409-025-02633-y]

Westin, J; Phillips, TJ; Mehta, A; Hoffmann, MS; Gonzalez-Barca, E; Thieblemont, C; Bastos-Oreiro, M; Greil, R; Giebel, S; Wei, MC; Wang, J; Bucher, R; Sit, J; Penuel, E; Purev, E; Yee, DL; Bergua-Burgues, JM.

Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study

Blood Advances. 2025; 9(10): 2461-2472 [doi:10.1182/bloodadvances.2024014907]

Battipaglia, G; Labopin, M; Kulagin, A; Versluis, J; Choi, G; Meijer, E; Rovira, M; van Gorkom, G; Kwon, M; Koc, Y; Vydra, J; Chiusolo, P; Patel, A; Piemontese, S; Sanz, J; Ruggeri, A; Nagler, A; Ciceri, F; Mohty, M.

Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT

BONE MARROW TRANSPLANTATION. 2025; : [doi:10.1038/s41409-025-02610-5]

González-Gil, C; Lopes, T; Morgades, M; Fuster-Tormo, F; Montesinos, P; Medina, CR; Hermosin, L; González-Martínez, T; Queipo, MP; González-Campos, J; Martínez-Sánchez, P; Díaz-Beya, M; Coll, R; Maluquer, C; Zamora, L; Artola, T; Vall-Llovera, F; Tormo, M; Torrent, A; Martínez-Laperche, C; Gil-Cortés, C; Barba, P; Cervera, M; Ribera, J; Fernández-Delgado, M; Ayala, R; Cladera, A; Mateos, MC; Vidal, MJ; Feliu, J; Torres, A; Azaceta, G; Calasanz, MJ; Bigas, A; Esteller, M; Orfao, A; Ribera, JM; Genescà, E.

Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials

Hemasphere. 2025; 9(5): [doi:10.1002/hem3.70148]

Puyo, PV; Christou, S; Campisi, S; Rodriguez-Sánchez, MA; Reidel, S; Perez-Hoyo, S; Mota, M; Savvidou, I; Rekleiti, A; Salvo, A; Voi, V; Ferrero, GB; Mandrile, G; Gaglioti, CM; Cela, E; Ponce-Salas, B; Bardón-Cancho, EJ; Flevari, P; Voskaridou-Dimoula, E; Nur, E; Biemond, BJ; Delaporta, P; Beneitez-Pastor, D; Gimbert, AC; Spasiano, A; Besse-Hammer, T; Lafiatis, IG; Dedeken, L; Raso, S; Ruiz-Llobet, A; Bagnato, S; Labarque, V; Glenthoj, A; Ruffo, GB; Guerzoni, ME; Hafraoui, K; Pistoia, L; Rosso, R; Tagliaferri, L; Gonzalez-Urdiales, P; Benghiat, FS; de Montalembert, M; Teles, MJ; Vanderfaeillie, A; Bertoni, E; Cuzzubbo, D; Ferreira, T; Saunders, CJ; Stiakaki, E; van de Velde, AL; Diamantidis, MD; Kerkhoffs, JLH; Oliveira, MI; Quota, A; Russo, R; Van Damme, A; Marina, MA; Reggiori, ML; Rijneveld, AW; Gallego, AR; Colombatti, R; Iolascon, A; Taher, A; Gulbis, B; Roy, NBA; Mañú-Pereira, MD.

COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet

ORPHANET JOURNAL OF RARE DISEASES. 2025; 20(1): [doi:10.1186/s13023-025-03683-7]

Encinas, C; Lozano, V; Hlavacek, P; Llinares, J; Toribio-Castelló, S; Carcedo, D; Asis-Montalt, J; Martínez-López, J.

Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain

Oncology And Therapy. 2025; 13(2): 381-395 Nº de citas: 1 [doi:10.1007/s40487-025-00333-7]

Pena-Burgos, EM; Agra-Pujol, C; Alijo-Serrano, F; Ferreira, LL; Santos, LM; Cuervo-Dehesa, M; Santos-Briz, A; García-Patos, PE; García, AT; Tapia-Viñe, M; Suárez-González, J; Pozo-Kreilinger, JJ.

Malignant chondroblastoma of the rib with scalp metastases in an adult patient: case report with molecular characterization

VIRCHOWS ARCHIV. 2025; : [doi:10.1007/s00428-025-04092-8]

Galán-Gómez, V; González-Martínez, B; Alonso-Saladrigues, A; Rives, S; Herrero, B; Kwon, M; Sánchez-Pina, J; Minguillón, J; Martínez-Romera, I; Aguilar, IM; Mestre-Durán, C; Casado, G; Sánchez-Martín, M; Echecopar, C; González-Pérez, C; León-Triana, O; Aguirre-Portolés, C; Molinos-Quintana, A; Barba, P; Balsalobre, P; Pérez-Martínez, A.

Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults

EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2025; 14(1): Nº de citas: 2 [doi:10.1186/s40164-025-00638-3]

Tedeschi, A; Auer, R; Autore, F; Castillo, JJ; Gatt, ME; Kimby, E; Moreno, DF; Owen, RG; Qiu, LG; Roccaro, AM; Sarosiek, S; Sekiguchi, N; Seymour, JF; Varettoni, M; Patterson, CJ; Matous, JV; Buske, C; Treon, SP; Sanz, RG.

Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma

SEMINARS IN HEMATOLOGY. 2025; 62(2): 106-112 Nº de citas: 1 [doi:10.1053/j.seminhematol.2025.04.002]

Gómez-Seguí, I; Cid, J; Lozano, M; Mingot-Castellano, ME; Pascual-Izquierdo, C; del Castillo, LMG; Estevez, JMV; Garcia-Candel, F; Balarezo, MJ; Valcarcel, D; Perez-Avila, CC; Ramirez, MA; Lakhwani, S; Jimenez, MGM; Hernandez, AYO; Gala, JMG; Nieto, JM; Goterris, R; Docampo, MF; Pell-Ilderton, CS; de la Rubia, J.

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry

Hemasphere. 2025; 9(4): Nº de citas: 1 [doi:10.1002/hem3.70109]

Stock, CNT; Chillón, CJ; Hernández, CL; Moro, FM; Palomanes, JM; Villaespesa, MP; de Abia, AL; Santiago, ER; Martín, ER; Rodríguez, AC; Gutiérrez, VG; Jiménez, GM; Jiménez, JL; Puente, PH.

Combination of disease burden before allogeneic transplantation and early post-transplant minimal residual disease predicts survival in patients with acute myeloid leukemia

ANNALS OF HEMATOLOGY. 2025; 104(4): 2469-2481 [doi:10.1007/s00277-025-06325-x]

Iacoboni, G; Rejeski, K; Navarro, V; van Meerten, T; Rampotas, A; Martin-López, AA; Bastos, M; Benzaquén, A; Reguera-Ortega, JL; Carpio, C; Roddie, C; López-Corral, L; Delgado-Serrano, J; Landwehr, M; Stock, S; de Tena, PS; Abrisqueta, P; de Boer, J; Garcia-Sancho, AM; Hernani, R; Kwon, M; Subklewe, M; O'Reilly, M; Barba, P.

Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy

LEUKEMIA. 2025; 39(5): 1196-1205 Nº de citas: 1 [doi:10.1038/s41375-025-02582-x]

Coppo, P; Bubenheim, M; Benhamou, Y; Voelker, L; Brinkkoetter, P; Kuehne, L; Knoebl, P; Mingot-Castellano, ME; Pascual-Izquierdo, C; de la Rubia, J; Garma, JD; Chaturvedi, S; Masias, C; Mazepa, M; Zheng, XL; Sinkovits, G; Reti, M; Patriquin, CJ; Pavenski, K; Boechat, T; Farias, J; Ribeiro, EFO; Andrade, MLLD; Veyradier, A; Joly, B; Bouzid, R; Sakai, K; Matsumoto, M; Agosti, P; Mancini, I; Peyvandi, F; Gavriilaki, E; Stubbs, M; Hmaid, A; Cataland, S; Laemmle, B; Scully, M.

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+project)

Eclinicalmedicine. 2025; 82: Nº de citas: 2 [doi:10.1016/j.eclinm.2025.103168]

Sureda, A; García-Sanz, R; Domingo-Domenech, E; Capote, FJ; Gutiérrez, A; Rodriguez, A; Aguiar, D; Giraldo, P; Infante, MS; López-Jiménez, J; Martínez, C; Sánchez-González, B; Ortiz-Romero, PL; Grande, M; Baeza-Montañez, L.

Retreatment with Brentuximab Vedotin in Patients with Relapsed/Refractory CD30+Malignancies: A Retrospective Medical Chart Review Study in Spain-The BELIEVE Study

Cancers. 2025; 17(7): [doi:10.3390/cancers17071137]

Poza, M; Martin-Muñoz, A; López-Pereira, P; Figaredo, G; Zamanillo, I; Iñiguez, R; Oliveira, AC; Baumann, T; Rodríguez-Izquierdo, A; Grande, C; Sarandeses, P; Revilla, E; Cortés, M; Ayala, R; Calbacho, M; Martínez, J; Barrio, S; Jiménez-Ubieto, A.

Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma

Cancers. 2025; 17(7): [doi:10.3390/cancers17071065]

Pena-Burgos, EM; del Carpio, GS; Tapia-Viñe, M; Suárez-González, J; Buño, I; Ortiz-Cruz, E; Pozo-Kreilinger, JJ.

Liposclerosing Myxofibrous Tumor: A Separated Clinical Entity?

Diagnostics. 2025; 15(5): [doi:10.3390/diagnostics15050536]

Camacho-Arteaga, L; Iacoboni, G; Kwon, M; Bailén, R; Hernani, R; Benzaquén, A; López-Corral, L; Pérez-López, E; Leguízamo-Martínez, LM; Calvo-Orteu, M; Guerreiro, M; Balaguer-Rosello, A; Alonso-Martínez, C; Vidal, X; Barba, P; Agustí, A.

Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

JAMA Network Open. 2025; 8(2): [doi:10.1001/jamanetworkopen.2024.61683]

Sanz, J; Labopin, M; Versluis, J; Blaise, D; Lazzari, L; Montoro, J; Van Gorkom, G; von dem Borne, P; Sandrine, L; Rovira, M; Remenyi, P; Chevallier, P; Kwon, M; Eder, M; Vydra, J; Brissot, E; Spyridonidis, A; Piemontese, S; Mohty, M; Ciceri, F.

Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT

BONE MARROW TRANSPLANTATION. 2025; 60(4): 529-534 Nº de citas: 1 [doi:10.1038/s41409-025-02527-z]